51 related articles for article (PubMed ID: 17353088)
1. Human ovarian carcinoma cells generate CD4(+)CD25(+) regulatory T cells from peripheral CD4(+)CD25(-) T cells through secreting TGF-beta.
Li X; Ye F; Chen H; Lu W; Wan X; Xie X
Cancer Lett; 2007 Aug; 253(1):144-53. PubMed ID: 17353088
[TBL] [Abstract][Full Text] [Related]
2. Human epithelial ovarian carcinoma cell-derived cytokines cooperatively induce activated CD4+CD25-CD45RA+ naïve T cells to express forkhead box protein 3 and exhibit suppressive ability in vitro.
Zhao X; Ye F; Chen L; Lu W; Xie X
Cancer Sci; 2009 Nov; 100(11):2143-51. PubMed ID: 19673890
[TBL] [Abstract][Full Text] [Related]
3. Legumain Regulates Regulatory T Cells in Hypertension.
Alexander MR; Harrison DG
Circ Res; 2024 Jan; 134(1):30-32. PubMed ID: 38175912
[No Abstract] [Full Text] [Related]
4. Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model.
Chang DK; Peterson E; Sun J; Goudie C; Drapkin RI; Liu JF; Matulonis U; Zhu Q; Marasco WA
Oncoimmunology; 2016 Mar; 5(3):e1090075. PubMed ID: 27141347
[TBL] [Abstract][Full Text] [Related]
5. Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma.
Wei H; Liu P; Swisher E; Yip YY; Tse JH; Agnew K; Hellström KE; Hellström I
J Immunother; 2012 Apr; 35(3):267-75. PubMed ID: 22421944
[TBL] [Abstract][Full Text] [Related]
6. CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.
Righi E; Kashiwagi S; Yuan J; Santosuosso M; Leblanc P; Ingraham R; Forbes B; Edelblute B; Collette B; Xing D; Kowalski M; Mingari MC; Vianello F; Birrer M; Orsulic S; Dranoff G; Poznansky MC
Cancer Res; 2011 Aug; 71(16):5522-5534. PubMed ID: 21742774
[TBL] [Abstract][Full Text] [Related]
7. Transformation Mechanism of Rare Ginsenosides in American Ginseng by Different Processing Methods and Antitumour Effects.
Li ZM; Shao ZJ; Qu D; Huo XH; Hua M; Chen JB; Lu YS; Sha JY; Li SS; Sun YS
Front Nutr; 2022; 9():833859. PubMed ID: 35445056
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian Cancer.
Rocconi RP; Stanbery L; Madeira da Silva L; Barrington RA; Aaron P; Manning L; Horvath S; Wallraven G; Bognar E; Walter A; Nemunaitis J
Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452019
[TBL] [Abstract][Full Text] [Related]
9. TGF-β2 is a Prognostic Biomarker Correlated with Immune Cell Infiltration in Colorectal Cancer: A STROBE-compliant article.
Tu Y; Han J; Dong Q; Chai R; Li N; Lu Q; Xiao Z; Guo Y; Wan Z; Xu Q
Medicine (Baltimore); 2020 Nov; 99(46):e23024. PubMed ID: 33181667
[TBL] [Abstract][Full Text] [Related]
10. Advances in Anti-Cancer Immunotherapy: Car-T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets.
Alard E; Butnariu AB; Grillo M; Kirkham C; Zinovkin DA; Newnham L; Macciochi J; Pranjol MZI
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32645977
[TBL] [Abstract][Full Text] [Related]
11. TGFβ2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer.
Xiao Z; Hu L; Yang L; Wang S; Gao Y; Zhu Q; Yang G; Huang D; Xu Q
J Cell Mol Med; 2020 Jul; 24(13):7151-7162. PubMed ID: 32530106
[TBL] [Abstract][Full Text] [Related]
12. Immune reaction by cytoreductive prostatectomy.
Lee GT; Srivastava A; Kwon YS; Kim IY
Am J Clin Exp Urol; 2019; 7(2):64-79. PubMed ID: 31139701
[TBL] [Abstract][Full Text] [Related]
13. C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer.
Wu S; He H; Liu H; Cao Y; Li R; Zhang H; Li H; Shen Z; Qin J; Xu J
Oncoimmunology; 2018; 7(6):e1433517. PubMed ID: 29872564
[TBL] [Abstract][Full Text] [Related]
14. Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment.
Yeku OO; Purdon TJ; Koneru M; Spriggs D; Brentjens RJ
Sci Rep; 2017 Sep; 7(1):10541. PubMed ID: 28874817
[TBL] [Abstract][Full Text] [Related]
15. Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells.
Surówka J; Wertel I; Okła K; Bednarek W; Tarkowski R; Kotarski J
Clin Transl Oncol; 2017 Dec; 19(12):1489-1497. PubMed ID: 28589429
[TBL] [Abstract][Full Text] [Related]
16. Adoptive T-Cell Therapy for Solid Tumors.
Yeku O; Li X; Brentjens RJ
Am Soc Clin Oncol Educ Book; 2017; 37():193-204. PubMed ID: 28561728
[TBL] [Abstract][Full Text] [Related]
17. Cancer-FOXP3 directly activated CCL5 to recruit FOXP3
Wang X; Lang M; Zhao T; Feng X; Zheng C; Huang C; Hao J; Dong J; Luo L; Li X; Lan C; Yu W; Yu M; Yang S; Ren H
Oncogene; 2017 May; 36(21):3048-3058. PubMed ID: 27991933
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment.
Wu M; Chen X; Lou J; Zhang S; Zhang X; Huang L; Sun R; Huang P; Wang F; Pan S
Oncotarget; 2016 Jul; 7(28):44534-44544. PubMed ID: 27322208
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients.
Wertel I; Surówka J; Polak G; Barczyński B; Bednarek W; Jakubowicz-Gil J; Bojarska-Junak A; Kotarski J
Tumour Biol; 2015 Jun; 36(6):4811-7. PubMed ID: 25647263
[TBL] [Abstract][Full Text] [Related]
20. High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment.
Ma GF; Miao Q; Liu YM; Gao H; Lian JJ; Wang YN; Zeng XQ; Luo TC; Ma LL; Shen ZB; Sun YH; Chen SY
Br J Cancer; 2014 Mar; 110(6):1552-60. PubMed ID: 24548868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
